It has been previously reported that TGF-β levels are high in the blood serum and tumor tissue of patients with malignant glioma and that this level was correlated with the type of malignancy, the tumor developmental stage, and the patient prognosis [10]. Here, TGFB1 is linked to malignant glioma.